AlphaStocks
8.4
Strong Buy

ASTRAZENECA PLC (AZN)

Health Care

ADR

$200.99

Above average across most dimensions. A solid candidate.

Strong Buy

Score based on 5 of 5 models — high confidence

#3out of 1127 in Health Care

Is ASTRAZENECA PLC a Good Investment in 2026?

ASTRAZENECA PLC (AZN) scores 8.4 out of 10 on AlphaStocks' composite model, earning a Strong Buy rating. The Piotroski model rates ASTRAZENECA PLC as Strong (8/9). However, the Graham model rates it Caution — Significantly above fair value. ASTRAZENECA PLC currently trades above its estimated fair value of $194, suggesting limited upside at current prices. ASTRAZENECA PLC ranks #3 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E30.4ROE21.9Market Cap312BDiv Yield1.6

Estimated Fair Value

$194.253% above

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Strong

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 3.6 · Stalwart

Greenblatt

Neutral

Top 10% (rank 6%)

Frequently Asked Questions

Is ASTRAZENECA PLC (AZN) a good investment?
Based on AlphaStocks' composite analysis, ASTRAZENECA PLC (AZN) scores 8.4 out of 10, earning a Strong Buy rating. This places it above average across most investment dimensions. Trading near estimated fair value.
What is ASTRAZENECA PLC's Piotroski F-Score?
ASTRAZENECA PLC's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AZN overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $194, AZN appears overvalued. The stock currently trades 3% above its estimated fair value. Trading near estimated fair value.
How does AZN compare to other Health Care stocks?
ASTRAZENECA PLC ranks #3 out of 1127 stocks in the Health Care sector, placing it in the top 0% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about AZN?
AlphaStocks evaluates AZN using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 8.4/10.

Similar Stocks

PARRFTIMATX

Compare AZN with

AZN vs PARRAZN vs FTIAZN vs MATX

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer